- Merrimack Pharmaceuticals (NASDAQ:MACK) CFO and Head of Corporate Development Dr. Yasir Al-Wakeel will resign effective June 9 to pursue other interests. A search has been initiated for a successor.
Merrimack finance chief bids adieu
Recommended For You
About MACK Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MACK | - | - |
Merrimack Pharmaceuticals, Inc. |